Advertisement
Dr. Coleman is a Professor of Ophthalmology in the Jules Stein EyeInstitute of the David Geffen School of Medicine at UCLA as well as Professorof Epidemiology in the UCLA School of Public Health. She holds the Frances andRay Stark Endowed Chair at UCLA and is Director of the Jules Stein EyeInstitute Mobile Eye Clinic. Dr. Coleman received her medical degree from theMedical College of Virginia, completed her fellowship training in glaucoma atthe Wilmer Eye Institute, Johns Hopkins University, and received a PhD inEpidemiology from UCLA in 1997.
Advertisement
Dr. Coleman's research is focused on the diagnosis, treatment, andsocietal impact of glaucoma, cataracts, andage-related macular degeneration (AMD), including the study of lifestylelimitations imposed on patients with these eye diseases. Currently an at-largemember of the American Academy of Ophthalmology's Board of Trustees, she is arecipient of the Academy's Senior Achievement Award and Secretariat Award.
"We are honored to welcome Dr. Coleman to the ScienceBased HealthScientific Advisory Board," said Alain Magro, president of ScienceBasedHealth. "Dr. Coleman brings to the Board a diverse background that will allowher to make significant contributions to our product development and researchendeavors. Her expertise in the areas of glaucoma and neuroprotection will beespecially valuable."
"I am pleased to be joining the ScienceBased Health Scientific AdvisoryBoard," said Anne L. Coleman, MD, PhD. "I am very interested in the interplaybetween nutrition and vision and my research interests include the effects ofantioxidants on glaucomatous optic nerve damage."
Dr. Coleman joins ScienceBased Health's existing Scientific Advisory Boardmembers: Paul S. Bernstein, MD, PhD, Associate Professor of Ophthalmology andVisual Sciences in the Retina Division at the Moran Eye Center, University ofUtah School of Medicine; David S. Boyer, MD, Senior Partner, Retina-VitreousAssociates Medical Group; Bert M. Glaser, MD, Executive Director, The NationalRetina Institute; Paul S. Koch, MD, Medical Director of Koch Eye Associates;Robert G. Martin, MD, Chief of Staff, Carolina Eye Associates and ChiefMedical Editor of Ophthalmology Times, Asia; Stephen C. Pflugfelder, MD,Director, Ocular Surface Center, Cullen Eye Institute at Baylor College ofMedicine; and John D. Sheppard, MD, MMSc, Ophthalmology Program Director atEastern Virginia Medical School, Clinical Director of the Thomas R. Lee Centerfor Ocular Pharmacology and Director of Virginia Eye Consultants.
About ScienceBased Health
ScienceBased Health, a privately held company, develops and marketsevidence-based nutraceuticals for eye health. The formulations, created byleading physicians, nutrition scientists and researchers, are based on thelatest scientific research and are recommended by thousands ofophthalmologists and optometrists nationwide. The Company developedHydroEye(R), a patented, oral formulation for dry eyes; OcularProtect(R), acomprehensive multinutrient for eyes and overall body health; MacularProtectComplete(R) and MacularProtect Complete(R)-S, powerful formulations, based onAREDS and other advanced research, to preserve macular and whole body health;Optic Nerve Formula(R), a powerful formulation to protect optic nerve health;and other high quality products for eye and body health. The products are madefrom premium ingredients and manufactured according to highest qualitystandards. For more information, contact ScienceBased Health at:(888) 433-4726 or visit: http://www.sciencebasedhealth.com.
SOURCE ScienceBased Health
